Theravance Biopharma Inc

TBPHNASDAQ
$16.91
-0.02-0.12%
Last update: Aug 10, 11:21 AM
Earnings: Q2 2026 earnings were released today before the market open

Theravance Biopharma Market Sentiment

Market sentiment signals for Theravance Biopharma (TBPH): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus Neutral
Short Interest 13.3% short float
Options Flow N/A
Insider Activity N/A

Analyst Consensus

Neutral

7 analysts

Options Flow (P/C)

0 calls · 1 puts

Avg Consensus PT

$15

-12.8%

Highest Price Target

$17

+0.5%

HC Wainwright & Co.

Lowest Price Target

$10

-40.9%

Leerink Partners

Short Interest

13.3%

Declining — Bullish

Insider Activity (30d)

Short Interest — % of Float

Recent Analyst Actions

DateFirmAnalyst & AccuracyUpside / DownsidePT ChangeActionRating
Jul 7, 2026HC Wainwright & Co.
Douglas Tsao
+0.5%$15 → $17DowngradeBuyNeutral
Jun 29, 2026Jones Trading
Debanjana Chatterjee
DowngradeBuyHold